If a test for multidrug-resistant tuberculosis (MDR-TB) does not detect an expected resistance marker, do not assume resistance is ruled out. Ask the treating clinician and laboratory to review the exact assay, specimen, result wording and clinical context, then decide whether repeat or alternative testing is needed. This article focuses on TB because that is where the available guidance is specific; if “MDR test” means a test for another organism, follow-up may differ. Share the test name and the exact wording of the result when asking about your own case.
What does “resistance not detected” mean?
It means the assay did not detect the resistance target or pattern it is designed to identify in that specimen. It is not necessarily proof that the organism is susceptible. A molecular assay tests for particular genetic targets; a resistance mechanism outside its coverage, a mutation that interferes with amplification, or a resistant subpopulation below the test’s detection limit may not be identified.
As an Amazon Associate I earn from qualifying purchases.
First distinguish whether the test detected the bacterium from whether it detected resistance. For example, an Xpert MTB/RIF report may say that Mycobacterium tuberculosis complex (MTBC) was detected while rifampin resistance was “not detected” or “indeterminate.” These are different findings, and “indeterminate” is not the same as a valid negative resistance result. Check the report and ask the laboratory to explain any validity flags or limitations for that specimen. CDC’s Xpert MTB/RIF guidance describes how to interpret these result categories.
Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Scan for outdated or missing drivers - takes under a minute3Clear out junk files and repair common Windows errorsWhat should you do next?
- Get the exact test details. Ask which assay and version was used, what specimen was tested, whether MTBC was detected, what the resistance result says verbatim, and whether the result was valid, indeterminate or otherwise limited.
- Explain why resistance was expected. Tell the clinician about prior TB treatment, known exposure to a drug-resistant case, relevant epidemiologic risks and whether symptoms or other findings have failed to improve. The clinician and TB program can weigh these details alongside imaging and other laboratory results.
- Ask the clinician and laboratory to review the discrepancy together. Depending on the assay and level of concern, they may consider a new specimen, a different molecular platform, sequencing, growth-based phenotypic drug-susceptibility testing (DST), or review for specimen-handling, laboratory or clerical error. The right combination is case-specific; WHO’s 2025 TB diagnostic guidance discusses these options for discordant findings.
- Confirm what culture and DST are planned. Molecular testing does not replace mycobacterial culture or growth-based DST. CDC advises that MTBC-positive specimens receive growth-based susceptibility testing to first-line TB drugs and states: “Regardless of the Xpert MTB/RIF result, patient specimens should also have mycobacterial culture to ensure isolates are available for drug susceptibility testing and genotyping.” CDC, Xpert MTB/RIF Assay.
- Leave treatment decisions to the treating team. A single molecular result should be interpreted with clinical, radiographic and other laboratory findings. Do not change or stop TB medicines based only on a “not detected” result; contact the treating team for instructions.
Why can a TB resistance test miss a marker?
The assay covers specific targets
Different molecular tests examine different regions or mutations. CDC’s 2024 guide for its Molecular Detection of Drug Resistance (MDDR) service says more than 95% of rifampin-resistant clinical isolates have a single point mutation in the 81-base-pair rpoB rifampin resistance-determining region, but that does not mean every assay covers every relevant mechanism. The same guide estimates that sequencing the fabG1-inhA promoter region, fabG1 and katG can detect 85–90% of isoniazid-resistant isolates. Neither figure is a universal sensitivity estimate for all tests.
#1 Best Overall
- REALISTIC FOREARM SIMULATION: TB testing model replicates a human forearm with palpable nodules, allowing learners to practice the Mantoux method. TB testing model presents four conditions with visible swelling and measurable induration for accurate interpretation
- TRUE-TO-LIFE MATERIALS: Soft silicone skin combined with a 3D-printed rigid core,TB testing Set provides a realistic feel when locating and assessing induration during training
- DUAL SKIN TONES: Two skin colors palpable arm set allow practice on different skin tones,helping improve accuracy in palpation and interpretation across diverse patient groups; The TB testing Set is durable for repeated use
- BUILT-IN MEASUREMENT GUIDE: A millimeter scale printed on the instruction panel helps learners measure induration diameter correctly, reinforcing proper TB test reading skills
- SAFE TRAINING APPLICATIONS: Palpable TB testing set suitable for classrooms, labs, and simulation courses, offering a safe and effective way to demonstrate and practice tuberculin skin test skills
Some resistance is hard to detect in a mixed population
A specimen can contain both susceptible and resistant bacteria. If the resistant fraction is too small for a particular method to detect, a molecular result may not show it. CDC notes that its MDDR sequencing can miss heteroresistance below the assay’s limit of detection, as well as mutations in genomic regions outside its coverage. Some mutations also have uncertain clinical significance, and sequencing and growth-based DST can disagree.
Molecular and phenotypic methods answer different questions
Molecular tests look for known genetic markers. Phenotypic DST assesses whether bacteria grow in the presence of drugs under specified laboratory conditions. WHO notes that molecular and phenotypic results do not always correlate; phenotypic testing remains important for surveillance classification. A discrepancy is a reason for expert review, not a reason to assume either test is automatically definitive.
Rank #2
- THE ORGINAL DIY BACTERIA TEST KIT that is certified accurate by Good Housekeeping Labs, American Red Cross, Underwriter Labs, and Merck Labs. Designed and developed by our EPA certified scientists. Made in the USA.
- PATENTED TECHNOLOGY: Detects 50 different species of coliform bacteria (including E. coli), as low as 1-organism. Test any freshwater supply.
- 3RD PARTY STERILIZATION: Every Safe Home kit is sterilized by a certified facility (see attached certificate) and guaranteed to be “free from bacteria” before you test. This process assures zero “false positive results” from product contamination, as may be experienced with other kits who skip this sterilization process.
- FAST RESULTS- Get results as quickly as 6 hours. May take up to 72 hours based on incubation conditions, and concentrations of bacteria in the water being tested.
- YOUR PURCHASE MAKES A DIFFERENCE in people’s lives. Safe Home donates a portion of every test kit sale to clean water initiatives around the globe. See attached images with this listing, to learn more.
How much confidence should you place in a negative result?
There is no single miss rate for an “MDR test.” It depends on the organism, assay, drug, specimen, resistance mechanism and the person’s risk of resistance before testing. WHO’s 2025 TB diagnostic guideline reports that 6–14% of isoniazid resistance may be missed by moderate-complexity automated nucleic acid amplification tests (MC-aNAATs) in the specified situation where isoniazid resistance is not detected and the person is at high risk of isoniazid-resistant TB. The same guideline reports false rifampin-susceptible results in 1–5% of rifampin-resistant TB cases tested with Xpert Ultra across epidemiological settings. These figures apply to those specified tests and situations, not to every molecular assay or every patient.
Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallMore generally, WHO’s 2019 technical note on molecular AMR diagnostics describes several ways a molecular result can be false-negative: the assay does not test the relevant resistance gene, a mutation affects primer binding, or resistance arises through a mechanism not yet characterized. This is why assay scope and the reason resistance was suspected matter when interpreting a result.
Rank #3
- Quick Results: Learn your blood type in just a couple of minutes with this easy-to-use testing kit
- Simple Interpretation: Easily understand your blood type group with clear and straightforward results
- Permanent Record: Keep as a permanent record of your blood type on the durable card for your records or safekeeping
- Reliable Accuracy: Offers a reliable and accurate way to learn your blood type using proven testing technology
- Convenient Home Use: Can be used conveniently at home without the need for laboratory visits
When is public-health laboratory support useful?
For TB cases with suspected drug resistance or conflicting results, clinicians can consult their public-health TB program and laboratory about specialized testing. In the United States, CDC describes its MDDR service as a sequencing and growth-based DST resource accessed through public-health laboratories; it can also assist with interpretation. It does not replace conventional culture and DST. Eligibility and submission procedures are specific to the CDC service, so confirm current arrangements with the relevant local or state TB program. CDC’s MDDR User Guide and CDC’s TB diagnosis guidance provide service and testing details.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Why the exact organism and test name matter
“MDR” is used in more than one infectious-disease context. For example, CDC’s material on methicillin-resistant Staphylococcus aureus discusses mixed susceptible and resistant bacterial subpopulations and organism-specific phenotypic testing and reporting rules. That is not a TB testing algorithm. If your report concerns an organism other than TB, ask the clinician or laboratory to interpret it using that organism’s specific assay and guidance. CDC’s MRSA laboratory testing information.
Quick Recap
Rank #4
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600+ places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- DNA + TRAITS: Ever wondered where your freckles came from, or why you hate cilantro? AncestryDNA + Traits lets you discover 75+ genetic traits, allowing you to explore how your genes might have influenced a range of appearance, sensory, performance, nutrient, and other personal characteristics.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA is the only DNA test that can show your origins results, DNA matches, and traits by each side of the family, without your parents taking a DNA test.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
